Enantioanalysis of bisoprolol in human plasma with a macrocyclic antibiotic HPLC chiral column using fluorescence detection and solid phase extraction

Chemical and Pharmaceutical Bulletin

Volumn 55, Issue 2, 2007, Pages 227-230

  Hefnawy, Mohamed Mohmoud ^a   Sultan, Maha Abd Alrahman ^a   Al Shehri, Mona Mohamed ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Bisoprolol; Fluorescence detection; Human plasma; Solid phase extraction; Teicoplanin column

Indexed keywords

ACETIC ACID; ANTIBIOTIC AGENT; ATENOLOL; BISOPROLOL; MACROCYCLIC COMPOUND; METHANOL; TEICOPLANIN; TRIETHYLAMINE;

ACCURACY; ARTICLE; CHIRALITY; CONTROLLED STUDY; DRUG BLOOD LEVEL; ENANTIOMER; ENANTIOSELECTIVITY; ENVIRONMENTAL TEMPERATURE; EXCITATION; FLOW RATE; FLUORESCENCE ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; QUANTITATIVE ASSAY; SOLID PHASE EXTRACTION; STANDARD; VALIDATION PROCESS;

ANTI-BACTERIAL AGENTS; BISOPROLOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLUORESCENCE; HUMANS; MACROCYCLIC COMPOUNDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOLID PHASE EXTRACTION; SOLVENTS; SPECTROMETRY, FLUORESCENCE; STEREOISOMERISM; TECHNOLOGY, PHARMACEUTICAL;

EID: 33846990958     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.55.227     Document Type: Article

References (19)

1. Ward T. J., Ward K. D., "On the Impact of Stereochemistry on Drug Development and Use," Chemical Analytical Series, ed. by Aboul-Enein H. Y., Wainer I., John Wiley & Sons, New York, 1997, 142, p. 317.
2. Aboul-Enein H. Y., Hefnawy M. M., Kenichiro N., "Drug Monitoring and Clinical Chemistry," ed. by Hempel G., Elsevier, Amsterdam, 2004, pp. 15-75.
3. Gunther K., "Handbook of TLC," ed. by Sherma J., Fried B., Marcel Dekker, New York, 1991, p. 541.
4. Aboul-Enein H. Y., Ali I., Chromatographia, 52, 679-686 (2000).
5. Simonyi M., Fitos I., Visy J., Trends Pharm. Sci., 7, 112-119 (1986).
6. Petro A., Lehmann F., Trends Pharm. Sci., 7, 281-287 (1986).
7. Walle T., Walle K. W., Trends Pharm. Sci., 7, 155-162 (1986).
8. Rojkovicova T., Lehotay J., Dungelova J., Cizmarik J., Armstrong D. W., J. Liq. Chromatogr. Rel. Technol., 25, 2723 (2002).
9. Armstrong D. W., Tan Y., Chen S., Zhou Y., Bagwill C., Chen I. R., Anal. Chem., 66, 1473-1484 (1994).
10. Tesarova E., Zaruba K., Flieger M., J. Chromatogr. A, 844, 137-147 (1999).
11. Ward T. J., Farris A. B. III, J. Chromatogr. A, 906, 73-89 (2001).
12. Aboul-Enein H. Y., Ali I., J. Liq. Chromatogr. Rel. Technol., 25, 2337-2352 (2002).
13. Schliep H. J., Harting J., J. Cardiovasc. Pharmacol., 6, 1156-1160 (1984).
14. Manalan A. S., Besch H. R., Watanabe A. M., Circ. Res., 49, 326-334 (1982).
15. Suzuki T., Horikiri Y., Mizobe M., Noda K., J. Chromatogr. Biomed. Appl., 619, 267-273 (1993).
16. Zhang X., Ouyang J., Baeyens W. R. G., Zhai S., Yang Y., Huang G., J. Pharm. Biomed. Anal., 31, 1047-1057 (2003).
17. "The United States Pharmacopeia," 24th 2dn., United States Pharmacopeial Convention, Rockville, MD, U.S.A., 2000, p. 2150.
18. Hefnawy M. M., Aboul-Enein H. Y., J. Pharm. Biomed. Anal., 35, 535-543 (2004).
19. Fried K. M., Koch P., Wainer I. W., Chirality, 10, 484-491 (1998).